Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Not applicable

Ultrasound-Guided Recto-Intercostal Fascial Plane Block in Laparoscopic Cholecystectomy

NCT07745972 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-08-06
Last updated
2026-08-10

Condition(s) studied

AnalgesiaPain ManagementPain, Acute Post-Operative

Investigational drug(s) / intervention(s)

Rectointercostal facial plane block using bupivacaine 0.25%

Rectointercostal facial plane block using bupivacaine 0.25%: Under ultrasound guidance, a total of 30 mL of solution will be administered bilaterally between the rectus abdominis muscle and the intercostal muscles, at the level of the 6th and 7th costal cartilages bilaterally.

Study summary

The aim of the study is to reduce postoperative pain by performing rectointercostal block in L/S cholecystectomy surgeries. Main goal is to provide well managed post-operative analgesia.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * BMI \< 35 kg/m² * Patients with ASA scores I and II Exclusion Criteria: * Patients who do not want to be included in the study * Psychiatric and neurological disease with blurred consciousness * Patients with ASA \> 3 * BMI \> 35 kg/m² * Abnormality in coagulation parameters * History of allergy to local anesthetic drugs * Infection at the injection site

Primary outcome measure(s)

  • Postoperative opioid consumption — 24 hours
    Contramal consumption in the first 24 hours after surgery

Trial sites (1)

FacilityCityRegionStatus
Istinye University Liv Topkapı Hospital Istanbul Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07745972 on ClinicalTrials.gov ↗ ← All trials in Turkey